The company is working with the U.S. regulator to move forward with an updated application, adding a decision is expected in ...
AstraZeneca has already provided the requested information to the FDA and a decision on the updated BLA is expected in the first half of 2026.
Subcutaneous anifrolumab is superior to placebo in multiple systemic lupus erythematosus disease activity measures at 52 ...
New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime ...
Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...
Small adjustments in handler positioning and equipment selection can make the difference between a successful treatment and a ...
Everyday Health on MSN
SCIg for primary immunodeficiency: Troubleshooting swelling, redness, and pain at the infusion site
Discover tips for managing swelling, redness, and pain at subcutaneous immunoglobulin (SCIg) infusion sites for primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results